Platelet counts and outcome in the pediatric intensive care unit

Shruti Agrawal1, Anil Sachdev, Dhiren Gupta

  • 1Pediatric Intensive Care, Sir Ganga Ram Hospital, New Delhi, India.

Insights

Thrombocytopenia is common in pediatric intensive care units (PICUs). A significant drop in platelet counts, even without full thrombocytopenia, is linked to higher mortality risk and bleeding in critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Hematology
  • Clinical Research

Background:

  • Thrombocytopenia is a frequent complication in critically ill pediatric patients.
  • Understanding its risk factors and impact on outcomes is crucial for patient management.

Purpose of the Study:

  • To evaluate platelet count variations and identify risk factors for thrombocytopenia in pediatric intensive care unit (PICU) patients.
  • To assess the prognostic value of platelet counts for mortality in this population.

Main Methods:

  • Prospective observational cohort study of 138 consecutively admitted patients to an 8-bedded PICU.
  • Data collected included platelet counts, Pediatric Risk of Mortality Score (PRISM), and clinical outcomes over a 7-month period.

Main Results:

  • Twenty-five percent of patients experienced thrombocytopenia, with 80% developing it during their PICU stay.
  • PICU-acquired thrombocytopenia was associated with lower platelet counts and a higher risk of bleeding.
  • Factors like PRISM score, prolonged PICU stay, sepsis, and coagulopathy were linked to thrombocytopenia and mortality.

Conclusions:

  • Thrombocytopenia is prevalent in PICU settings and associated with increased bleeding risk.
  • A platelet count drop greater than 27% and thrombocytopenia are independent predictors of mortality.
  • Serial platelet count monitoring offers better prognostic value than single measurements for predicting pediatric intensive care outcomes.
Abstract

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...